SGLT2 Inhibitors Linked With Fewer Gout Flares in Diabetes SGLT2 Inhibitors Linked With Fewer Gout Flares in Diabetes
In 8150 propensity-score matched Canadians with gout and type 2 diabetes, treatment with an SGLT2 inhibitor was linked with a significant 34% relative drop in gout flares compared with DPP-4 inhibitors.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 24, 2023 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news
The Link Between Gout and Depression: What to Know
Gout is a form of arthritis that causes intense pain, redness, and swelling of the joints and extremities. If it’s not treated, it can lead to high blood pressure, heart attacks, diabetes, kidney problems, and obesity. Now, researchers are taking a closer look at another health challenge linked to gout: depression. (Source: WebMD Health)
Source: WebMD Health - July 20, 2023 Category: Consumer Health News Source Type: news
EULAR Issues Imaging Recommendations for Gout, CPPD EULAR Issues Imaging Recommendations for Gout, CPPD
The document provides guidance on using imaging in the diagnosis and management of all common forms of crystal-induced arthropathies.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - June 16, 2023 Category: Internal Medicine Tags: Rheumatology News Source Type: news
Gout Linked to Smaller Brain Volume, Neurodegeneration Risk Gout Linked to Smaller Brain Volume, Neurodegeneration Risk
Patients with gout may have smaller brains with more iron, and they may be at increased risk for dementia and other neurodegenerative diseases, particularly in the first 3 years after diagnosis.MDedge News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 8, 2023 Category: Primary Care Tags: Rheumatology News Source Type: news
Gout Linked to Smaller Brain Volume, Neurodegeneration Risk Gout Linked to Smaller Brain Volume, Neurodegeneration Risk
Patients with gout may have smaller brains with more iron, and they may be at increased risk for dementia and other neurodegenerative diseases, particularly in the first 3 years after diagnosis.MDedge News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 8, 2023 Category: Rheumatology Tags: Rheumatology News Source Type: news
Warning that drinking ANY amount of alcohol may raise risk of 60 diseases
Oxford University researchers, who looked at data on half a million men in China, found that drinking alcohol can raise the chances of developing gout, cataracts and fractures. (Source: the Mail online | Health)
Source: the Mail online | Health - June 8, 2023 Category: Consumer Health News Source Type: news
Uricase-Based Gout Drug Meets Endpoints in Phase 3 Trials Uricase-Based Gout Drug Meets Endpoints in Phase 3 Trials
Two phase 3 trials of the once-monthly SEL-212 in refractory gout achieved and maintained serum uric acid (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 7, 2023 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
URAT1 Inhibitor Shows'Substantial' Cut in Uric Acid in Gout URAT1 Inhibitor Shows'Substantial' Cut in Uric Acid in Gout
The investigational drug AR882 reduced serum uric acid to levels seen in people without hyperuricemia and gout.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 5, 2023 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
Two-Drug Combo Wins for Refractory Gout
(MedPage Today) -- MILAN -- About half of patients receiving infusions of a novel uricase analog, along with a proprietary rapamycin formulation, in two similarly designed phase III studies got their serum urate under control, after multiple... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - June 3, 2023 Category: Rheumatology Source Type: news
More Evidence Backs Gout Benefit for Gliflozin Agents
(MedPage Today) -- MILAN -- Canadian patients taking sodium-glucose cotransporter-2 (SGLT-2) inhibitors for type 2 diabetes saw reductions in rates of incident gout, ranging from about 40% to 60% relative to three other classes typically added... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 2, 2023 Category: Endocrinology Source Type: news
June 2023
An Uptick in Ticks : Don ’t Let Ticks Make You Sick
Easing Depression in Older Adults
What Are Frontotemporal Disorders? : Dementias That Happen in Midlife
Living With Gout
NIH Spanish Health Information Portal (Source: NIH News in Health)
Source: NIH News in Health - May 31, 2023 Category: Consumer Health News Source Type: news
Colchicine Price Increase Tied to Poorer Gout Control Over a Decade
WEDNESDAY, May 17, 2023 -- A sharp increase in colchicine prices in 2010 was associated with a sustained decrease in colchicine use and poorer disease control over a decade, according to a study published online May 8 in JAMA Internal Medicine.
Dan... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2023 Category: Pharmaceuticals Source Type: news
US for Diagnosing Gout and CPPD in Acute Mono/Oligoarthritis US for Diagnosing Gout and CPPD in Acute Mono/Oligoarthritis
This article describes a targeted US scanning protocol for diagnosing gout and CPPD in patient with acute mono/oligoarthritis. How accurate is it?Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 12, 2023 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Colchicine's 2010 Price Spike Had Major Impact on Gout Care Colchicine's 2010 Price Spike Had Major Impact on Gout Care
Colchicine prescriptions dropped sharply and patient visits for gout-related symptoms increased significantly after a 2010 US Food and Drug Administration ruling that enabled a price spike.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 8, 2023 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
UA-Block contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use UA-Block, a product promoted and sold for joint pain and inflammation, pain from gout, and liver detoxification on various websites and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 8, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
